News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Decheng Capital China Life Sciences USD Fund III, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2022 |
4
| Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 639,456 shares
@ $7.35, valued at
$4.7M
Granted 1,360,544 shares
@ $7.35, valued at
$10M
|
|
| 09/27/2022 |
SC 13D/A
| Decheng Capital China Life Sciences USD Fund III, L.P. reports a 17.6% stake in Alpine Immune Sciences, Inc. |
| 09/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/08/2020 |
SC 13D/A
| Decheng Capital China Life Sciences USD Fund III, L.P. reports a 13% stake in BeyondSpring Inc. |
| 07/31/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/27/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/23/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/02/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/24/2019 |
SC 13D
| Decheng Capital China Life Sciences USD Fund III, L.P. reports a 19.9% stake in Alpine Immune Sciences, Inc. |
| 01/23/2019 |
3
| Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
| 04/30/2018 |
D
| Form D - Notice of Exempt Offering of Securities: |
|
|